
Effective transfer and expression of the gene of interest (GOI) is the key step in B cell engineering. Our gene-editing platform and delivery system confers high efficiency of gene transfer into primary mouse B cells, promoting the development of B cell-based therapy. https://www.creative-biolabs.com/b-cell-therapeutics/primary-mouse-b-cell-engineering.htm